Turkish Lower-Extremity Motor Activity Log (LE-MAL)
Launched by GAZIANTEP ISLAM SCIENCE AND TECHNOLOGY UNIVERSITY · Nov 27, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Turkish Lower-Extremity Motor Activity Log (LE-MAL), is focused on understanding how people who have had a stroke use their legs during daily activities. The study involves a special survey where participants will rate how often they use their legs for 14 different activities. This tool aims to provide insights into real-life movement, helping to improve care for individuals with stroke and similar conditions, like spastic paraplegia.
To be eligible for this trial, participants must be between 18 and 80 years old, live in Gaziantep, and have been diagnosed with a stroke. However, individuals with a recent history of trauma, those struggling with alcohol or substance addiction, or women who are pregnant cannot participate. If you join the study, you can expect to complete a series of questions about your leg movements in everyday tasks, contributing valuable information to help enhance treatment and support for others facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals between the ages of 18-80 living in Gaziantep who applied to the neurology outpatient clinic of Hospital and were diagnosed with stroke.
- Exclusion Criteria:
- • Patients with a history of trauma within the last year, alcohol and substance addiction, and pregnancy
About Gaziantep Islam Science And Technology University
Gaziantep Islam Science and Technology University is a leading academic institution dedicated to advancing research and innovation in the fields of science and technology. With a focus on interdisciplinary collaboration, the university fosters a rigorous environment for clinical research, emphasizing ethical practices and the translation of scientific discoveries into practical applications. The institution is committed to enhancing public health outcomes through its clinical trials, which aim to explore new methodologies and treatments. By leveraging its expertise and resources, Gaziantep Islam Science and Technology University plays a vital role in contributing to the global scientific community and improving healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gaziantep, , Turkey
Patients applied
Trial Officials
Zekiye İpek Katırcı Kırmacı
Principal Investigator
Gaziantep Islam Science and Technology University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported